COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review

doi:10.5501/wjv.v10.i6.312

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6425)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

447

WORD

199

HTML

3279

Figures (1-1)

412

Tables (1-3)

567

Sum=4904

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

279

Download

438

Sum=717

Publishing Process of This Article

Item

Count

Browse

338

Download

466

Sum=804

Nov 25, 2021 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Virol. Nov 25, 2021; 10(6): 312-325
Published online Nov 25, 2021. doi: 10.5501/wjv.v10.i6.312

Full Size Figure Download Figure

Figure 1 Number of lymphoma patients described all over the world in largest hematologic malignancy studies. UK: United Kingdom; USA: United States of America.

Citation: Bonuomo V, Ferrarini I, Dell'Eva M, Sbisà E, Krampera M, Visco C. COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review. World J Virol 2021; 10(6): 312-325
URL: https://www.wjgnet.com/2220-3249/full/v10/i6/312.htm
DOI: https://dx.doi.org/10.5501/wjv.v10.i6.312